Integral Derivatives’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$395K Sell
5,100
-7,000
-58% -$564K 0.01% 449
2017
Q4
$1.02M Buy
12,100
+200
+2% +$17K 0.02% 471
2017
Q3
$1.02M Sell
11,900
-200
-2% -$16.4K 0.02% 491
2017
Q2
$996K Sell
12,100
-3,300
-21% -$269K 0.02% 488
2017
Q1
$1.29M Sell
15,400
-28,400
-65% -$2.27M 0.02% 444
2016
Q4
$3.22M Buy
43,800
+800
+2% +$59.6K 0.06% 205
2016
Q3
$3.45M Buy
43,000
+25,200
+142% +$2.02M 0.07% 161
2016
Q2
$1.4M Buy
+17,800
New +$1.34M 0.03% 314
2015
Q4
Sell
-5,800
Closed -$485K 1151
2015
Q3
$485K Buy
+5,800
New +$490K 0.01% 719
2015
Q1
Sell
-51,600
Closed -$3.56M 1268
2014
Q4
$3.56M Sell
51,600
-18,400
-26% -$1.24M 0.06% 264
2014
Q3
$4.54M Sell
70,000
-56,700
-45% -$3.59M 0.08% 216
2014
Q2
$7.88M Buy
126,700
+66,900
+112% +$3.99M 0.14% 109
2014
Q1
$3.52M Buy
59,800
+19,900
+50% +$1.11M 0.07% 259
2013
Q4
$2.04M Buy
+39,900
New +$2M 0.03% 483

Other funds holding LLY

Integral Derivatives's LLY Position: Q3 2016 in Review

Integral Derivatives sold out of Eli Lilly (LLY) in Q3 2016, closing a stake of 10,675 shares — an estimated $854K sold.

Integral Derivatives first reported a position in LLY in Q1 2014 and held it in 5 quarters. The position peaked at $1.99M in Q3 2014. 1,176 funds tracked by Wall St. Rank hold LLY as of Q3 2016.

  • Integral Derivatives reported no remaining Eli Lilly position as of Q3 2016 after selling out during the quarter.
  • Integral Derivatives sold 10,675 Eli Lilly shares in Q3 2016, an estimated $854K.
  • Integral Derivatives first reported a position in Eli Lilly in Q1 2014 and held it in 5 quarters.
  • Integral Derivatives's Eli Lilly position peaked at $1.99M in Q3 2014.
  • 1,176 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2016.

Based on Integral Derivatives's 13F filing for Q3 2016, filed 14 Nov 2016.